Pharmaceutical industry – Page 7
-
Opinion
Beyond the ChatGPT hype
Large language models can be powerful tools for chemistry if we acknowledge their limits
-
Business
Fines upheld for Advanz Pharma over thyroid drug price increases
UK competition tribunal rules liothyronine pricing ’excessive’ and ‘deliberate’
-
Opinion
Navigating the literature torrent
It’s humanly impossible to filter and read everything worthwhile – let’s embrace assistance
-
Business
Antibodies face Alzheimer’s reality
Companies are convincing regulators, but will doctors use them, and will providers pay for them?
-
Business
Biogen to cut 1000 more jobs by 2025
Biotech giant has also agreed to buy Reata Pharmaceuticals for $7.3 billion
-
Business
Illumina’s Grail quest results in epic fine
EU and US competition authorities object to firms completing merger without approval
-
Article
Mimicking our eyes’ sun protection
Sóliome is developing sunscreens based on natural UV-filtering peptides
-
Business
J&J subsidiary sues more talc researchers
Lawsuit claims another study linking talc use to cancer is fraudulent
-
Business
Revolutionising RSV prevention
New vaccines and a long-acting antibody aim to protect older adults and babies from respiratory syncytial virus
-
Research
AI can suggest Covid-19 antivirals from protein sequence alone
IBM model can also find molecules that bind at different sites on target proteins
-
Opinion
Bringing drug manufacturing back home
Pharmaceutical supply chains are international, complex and opaque. Is there a better way?
-
Research
Colour-changing liquids could flag cold chain breaches for medicines
Device offers simple and reliable monitoring with no electronic waste
-
Business
US trade regulator sues to block Amgen–Horizon merger
Federal Trade Commission has concerns that union will allow Amgen to stifle potential competition for Horizon’s drugs
-
Business
The diabetes drugs aiming to aid weight loss
Can peptide hormone mimics avoid the side effect pitfalls of previous weight loss treatments?
-
Business
US supreme court confirms Amgen’s cholesterol antibody patents invalid
Decision could mean patent descriptions need to be even more detailed, and hence expensive
-
Opinion
Regulators must follow their heads, not their hearts
The 2019 US approval of antibiotic Recarbrio seems not to have met the normally expected standards
-
Webinar
Building organisational consensus around the tools of digital chemistry
Learn how change agents at Johnson Matthey developed a coalition of support for data-driven science
-
Business
Deadly explosion and fire at US pharmaceutical plant
One worker killed and four hospitalised at Seqens in Newburyport
-
Opinion
Will a court overturn abortion drug’s approval?
Tangle between regulation and politics makes uncomfortable viewing from industry
-
Business
Merck & Co to buy immunology specialist Prometheus
$10.8 billion cash deal give Merck rights to late-stage candidate for two inflammatory bowel conditions